Laurent Peyrin-Biroulet is professor of medicine and head of the inflammatory bowel disease (IBD) unit (Inserm U1256 NGERE) at the Nancy University Hospital in France. Upon receiving his medical degree and PhD, he undertook a postdoctoral fellowship at the IBD Centre in Lille in 2007, before taking a research position at the Mayo Clinic in Rochester, USA (2008–2009).
Professor Peyrin-Biroulet received a rising star award in 2008 from the United European Gastroenterology Federation (UEGF). He is President of the GETAID and Past-President of the SciCom of the French association of IBD patients (AFA). He is past-Chair of the IBD Committee of the French Society of Digestive Endoscopy (SFED) and Past-Chair of the Clinical Trials Task Force at IOIBD. He was member of the UEGF Scientific Committee (2011-14). He is the current President elect of the European Crohn’s & Colitis Organization (ECCO) and current scientific secretary of IOIBD. He was the coordinator for the development of the first Disability Index for IBD and of the treat to target (STRIDE) recommendations. He proposed the first definitions of early Crohn’s disease and of disease severity for IBD. He is co-founder of the Spectrum consortium and President of the ICARE project. Author of more than 700 peer-reviewed articles and more than 200 non peer-reviewed articles, Professor Peyrin-Biroulet was an associate editor of Digestive Liver Diseases (2013-17), and is a member of the editorial board of Alimentary Pharmacology & Therapeutics, Journal of Crohn’s and colitis, Expert Review of Clinical Immunology, and Gut. He is Associate Editor of Clinical Gastroenterology Hepatology since 2017. He also serves as a reviewer for several international journals and he is a staff contributor of the Selected Summary section of Gastroenterology. He joined the editorial team of the Cochrane Inflammatory Bowel Diseases and Functional Bowel Disorders (IBD/FBD) Review Group in 2014. He served as Councillor to the Immunology, Microbiology and IBD section of the AGA Institute Council (2014-2016).EM-39423 - Date of preparation: August 2020